2seventy bio (NASDAQ:TSVT) Receives “Sell (E+)” Rating from Weiss Ratings

Weiss Ratings reissued their sell (e+) rating on shares of 2seventy bio (NASDAQ:TSVT – Free Report) in a research report sent to investors on Saturday,Weiss Ratings reports. 2seventy bio Price Performance NASDAQ:TSVT traded up $0.17 during trading hours on Friday, reaching $2.61. 380,020 shares of the company were exchanged, compared to its average volume of […]

Leave a Reply

Your email address will not be published.

Previous post 4D Molecular Therapeutics’ (FDMT) Sell (D-) Rating Reaffirmed at Weiss Ratings
Next post Cipher Mining Inc. (NASDAQ:CIFR) Short Interest Update